1. Markowitz JA, Singh P and Darras BT: Spinal muscular atrophy:

A clinical and research update. Pediatr Neurol 46: 1-12, 2012. 2. Scheffer H, Cobben JM, Matthijs G and Wirth B: Best practice guidelines for molecular analysis in spinal muscular atrophy. Eur J Hum Genet 9: 484-491, 2001.

3. Prior TW: Perspectives and diagnostic considerations in spinal muscular atrophy. Genet Med 12: 145-152, 2010.

4. Hendrickson BC, Donohoe C, Akmaev VR, et al: Differences in SMN1 allele frequencies among ethnic groups within North America. J Med Genet 46: 641-644, 2009.

5. Jedrzejowska M, Milewski M, Zimowski J, et al: Phenotype modifiers of spinal muscular atrophy: The number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease. Acta Biochim Pol 56: 103-108, 2009.

6. Monani UR and De Vivo DC: Neurodegeneration in spinal muscular atrophy: From disease phenotype and animal models to therapeutic strategies and beyond. Future Neurol 9: 49-65, 2014.

7. Ogino S, Leonard DG, Rennert H, Ewens WJ and Wilson RB: Genetic risk assessment in carrier testing for spinal muscular atrophy. Am J Med Genet 110: 301-307, 2002.

8. Majumdar R, Rehana Z, Al Jumah M and Fetaini N: Spinal muscular atrophy carrier screening by multiplex polymerase chain reaction using dried blood spot on filter paper. Ann Hum Genet 69: 216-221, 2005.

9. Hasanzad M, Golkar Z, Kariminejad R, et al: Deletions in the survival motor neuron gene in Iranian patients with spinal muscular atrophy. Ann Acad Med Singapore 38: 139-141, 2009.

10. Hasanzad M, Azad M, Kahrizi K, et al: Carrier frequency of SMA by quantitative analysis of the SMN1 deletion in the Iranian population. Eur J Neurol 17: 160-162, 2010.

11. Dobrowolski SF, Pham HT, Downes FP, Prior TW, Naylor EW and Swoboda KJ: Newborn screening for spinal muscular atrophy by calibrated short-amplicon melt profiling. Clin Chem 58: 1033-1039, 2012.

12. Wirth B, Herz M, Wetter A, et al: Quantitative analysis of survival motor neuron copies: Identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation and implications for genetic counseling. Am J Hum Genet 64: 1340-1356, 1999. 

13. Tizzano E and Baiget M: Molecular basis of spinal muscular atrophy: The SMN gene. Neurologia 15: 393-400, 2000 (In Spanish). 

14. Sumner CJ: Therapeutics development for spinal muscular atrophy. NeuroRx 3: 235-245, 2006. 

15. Singh NN and Singh RN: Alternative splicing in spinal muscular atrophy underscores the role of an intron definition model. RNA Biol 8: 600-606, 2011. 

16. Yu-Jin Q, Juan D, Er-zhen L, et al: Subtle mutations in the SMN1 gene in Chinese patients with SMA: p.Arg288Met mutation causing SMN1 transcript exclusion of exon7. BMC Med Genet 13: 86, 2012. 

17. Monani UR, McPherson JD and Burghes AH: Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT). Biochim Biophys Acta 1445: 330-336, 1999. 

18. Anhuf D, Eggermann T, Rudnik-Schöneborn S and Zerres K: Determination of SMN1 and SMN2 copy number using TaqMan technology. Hum Mutat 22: 74-78, 2003. 

19. Yoon S, Lee CH and Lee KA: Determination of SMN1 and SMN2 copy numbers in a Korean population using multiplex ligation-dependent probe amplification. Korean J Lab Med 30: 93-96, 2010. 

20. Ye S, Dhillon S, Ke X, Collins AR and Day IN: An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 29: E88-E88, 2001. 

21. Cheng CY, Kao WH, Patterson N, et al: Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. PLoS Genet 5: e1000490, 2009.

22. Guthrie PA, Gaunt TR, Abdollahi MR, et al: Amplification ratio

control system for copy number variation genotyping. Nucleic

Acids Res 39: e54, 2011. 23. Ben-Shachar S, Orr-Urtreger A, Bardugo E, Shomrat R and Yaron Y: Large-scale population screening for spinal muscular

atrophy: Clinical implications. Genet Med 13: 110-114, 2011.

24. Wirth B: An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 15: 228-237, 2000.

25. Muralidharan K, Wilson RB, Ogino S, Nagan N, Curtis C and

Schrijver I: Population carrier screening for spinal muscular

atrophy a position statement of the association for molecular pathology. J Mol Diagn 13: 3-6, 2011. 26. Siegel R, Naishadham D and Jemal A: Cancer statistics for Hispanics/Latinos, 2012. CA: Cancer J Clin 62: 283-298, 2012. 27. Sugarman EA, Nagan N, Zhu H, et al: Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy:

Clinical laboratory analysis of >72,400 specimens. Eur J Hum

Genet 20: 27-32, 2012.

28. Moreno-Estrada A, Gignoux CR, Fernández-López JC, et al: Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. Science 344: 1280-1285, 2014.

29. Basel-Vanagaite L, Taub E, Drasinover V, et al: Genetic carrier screening for spinal muscular atrophy and spinal muscular

atrophy with respiratory distress 1 in an isolated population in

Israel. Genet Test 12: 53-56, 2008.

30. Arkblad E, Tulinius M, Kroksmark AK, Henricsson M and

Darin N: A population-based study of genotypic and phenotypic

variability in children with spinal muscular atrophy. Acta Paediatr 98: 865-872, 2009.